Elan completes recovery plan ahead of target

Pharmaceutical company Elan Corporation, has announced the completion of the sale of its European sales and marketing business to Medeus Pharma, a new UK pharmaceutical company backed by private equity firm Apax Partners Funds.

Pharmaceutical company Elan Corporation, has announced the completion of the sale of its European sales and marketing business to Medeus Pharma, a new UK pharmaceutical company backed by private equity firm Apax Partners Funds.

Elan has raised around $120m (€93.7m) from the sale, which was first announced in late December.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited